Standout Papers

Type I interferon is selectively required by dendritic cells for immune rejection of tumors 2011 2026 2016 2021 854
  1. Type I interferon is selectively required by dendritic cells for immune rejection of tumors (2011)
    Mark S. Diamond, Michelle Kinder et al. The Journal of Experimental Medicine

Immediate Impact

10 by Nobel laureates 23 from Science/Nature 101 standout
Sub-graph 1 of 18

Citing Papers

Targeting innate immune pathways for cancer immunotherapy
2023 Standout
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
2022 Standout
35 intermediate papers

Works of Michelle Kinder being referenced

Type I interferon is selectively required by dendritic cells for immune rejection of tumors
2011 Standout

Author Peers

Author Last Decade Papers Cites
Michelle Kinder 1013 597 418 20 1.5k
Suman Mitra 921 496 361 28 1.4k
Sašo Čemerski 1219 375 431 21 1.7k
Iris Castro 884 417 397 27 1.5k
Anna Wasiuk 1528 835 388 17 2.1k
Naoko Nakano 1264 517 404 26 1.8k
Janet E. Buhlmann 1428 464 339 20 1.9k
S Pestka 1087 700 360 31 1.6k
René Conings 890 855 425 26 1.7k
Patricia Corthésy 1626 611 459 25 2.1k
Josiane Ragimbeau 743 366 304 20 1.2k

All Works

Loading papers...

Rankless by CCL
2026